CytRx Reports Q3 Financial Results
13th Nov 2006, 22:53 GMT
CytRx Corp, a biopharmaceutical company engaged in the development and commercialization of human therapeutics, reported financial results for the 3 months and 9 months ended 9/30/2006.
CytRx Reports Q3 Financial Results related news:
- Adherex Reports Q3 2006 Financial Results — Radiology News from StratCenter.com
- Favrille Reports Q3 2006 Financial Results — StratWire - Business of Healthcare NewsFeed
- Alexza Reports Q3 Financial Results and Updates Status of Development Pipeline — StratWire - Business of Healthcare NewsFeed
- Nymox Reports Q3 2006 Financial Results — Pharmaceuticals News from StratCenter.com
- Aksys Reports Q3 2006 Financial Results — Nephrology/ Dialysis News from StratCenter.com
- BioSante Pharmaceuticals Reports Q3 2006 Financial Results And Reviews Bio-E-Gel Marketing Agreement — Operations-Related News from StratCenter.com
- Stratagene Reports Q3 Results — Laboratory News from StratCenter.com
- Cardiogenesis Reports Q3 2006 Results — Surgery News from StratCenter.com
- Opexa Reports Q3 Financial Results — Nephrology/ Dialysis News from StratCenter.com
- Acusphere Reports Q3 2006 Financial Results and Accomplishments — Obstetrics/ Gynecology News from StratCenter.com
Latest news from Bio-Technology News from StratCenter.com:
- IBT Labs Invests $2 mln to Expand Pharmaceutical Services Division
- Mercury Computer Systems Collaborates with Boston Univ to Deliver Biotech Application on the Cell BE Processor
- Nabi Biopharmaceuticals and 3rd Point Reach Agreement
- Epratuzumab and Rituximab Have Different Modes of Action
- avVaa World Health Care Products Signs New Spokesman
- China Biopharma Delivers 1.5 mln Doses of Flu Vaccine in China
- Osteologix Appoints Jeremy Curnock Cook to its Board
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma
- Medarex to Receive Milestone Payment from Amgen
- Arqule Early Cancer Study Shows Progress